ArticleInvestigational new drugs2021

Potent synergistic anti-tumor activity of a novel humanized anti-HER2 antibody hersintuzumab in combination with trastuzumab in xenograft models.

Fariba Shiravi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.